February 25, 2021 February 25, 2021Categories Active Clinical TrialsNow Enrolling: EA3191 for Head and Neck Squamous Cell CarcinomaThis three-arm phase II study, led by Dr. Dan Zandberg, is evaluating pembrolizumab immunotherapy after surgery in patients with recurrent or second primary head and neck cancer with high-risk features
July 29, 2020 July 29, 2020Categories PeopleRemembering Sanjiv Sam Gambhir, MD, PhDIn July, the field of radiology lost one its most influential leaders